Uterine Body Mixed Cancer, also known as malignant mixed tumor, not otherwise specified, is related to uterine carcinosarcoma and uterine corpus adenocarcinofibroma. An important gene associated with Uterine Body Mixed Cancer is TP53 (Tumor Protein P53), and among its related pathways/superpathways are Gene expression (Transcription) and Innate Immune System. Related phenotypes are Decreased viability and Increased shRNA abundance (Z-score > 2)